bearish
SELL Hengan (1044 HK): Thesis Confirmed
467 Views24 Aug 2018 13:12
In our June'18 note on Hengan we noted our concerns with Related parties, Debt churn and Margin pressure.The H1 FY18 results appear confirm our...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 47-minute read)
Discussions
(Paid Plans Only)
Bucephalus Research Partnership
Exposing Creative Accounting
Price Chart(Sign Up to Access)
- Hengan (1044) Vs Vinda (3331): Which One?08 Apr 2020
- Prefer Vinda Even If Hengan Surprises Near-Term; CG Issues Need More Light14 Jan 2020
- BUY Vinda (3331 HK): Thesis Confirmed24 Aug 2018
- SELL Hengan (1044 HK): Thesis Confirmed24 Aug 2018
- Buy Vinda (3331 HK): New Incentives, Leverage & Margins - Target HK$25.2 (Up 80%+)13 Aug 2018
- Sell Hengan (1044 HK): Relationships, Churn & Margin Pressure. Target HK$38 (Down 50%)13 Aug 2018
x